RN7SL544P

Across TCGA pan-cancer cohorts, RN7SL544P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SL544P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL544P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL544P expression acts as an unfavorable survival marker.

HNSC, KIRC, and KIRP are the cancer types where RN7SL544P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.059	0.751	<.001	144	view →
KIRC	DFS	Tertile	II,III,IV	0.002	0.762	<.001	72	view →
KIRP	DFS	Tertile	II,III,IV	0.191	0.781	<.001	45	view →
SKCM	DFS	Tertile	III,IV	0.037	0.613	<.001	30	view →
STAD	OS	Tertile	II,III,IV	0.285	0.714	.011	18	view →
COAD	DFS	Tertile	All	0.160	0.693	.020	18	view →
BRCA	OS	Tertile	II,III,IV	0.210	0.567	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SL544P–HNSC (OS)

Open the HNSC breakdown →